NM
Newtyn Management Portfolio holdings
AUM
$817M
1-Year Est. Return
19.88%
1 Year Est. Return
+19.88%
AUM
$660M
AUM Growth
+$27.9M
(+4.4%)
Holding
40
Top Buys
| 1 | +$25.7M | |
| 2 | +$14.1M | |
| 3 | +$14.1M | |
| 4 |
SITE Centers
SITC
|
+$12.4M |
| 5 |
MAGN
Magnera Corp
MAGN
|
+$11.7M |
Top Sells
| 1 | +$34M | |
| 2 | +$27.5M | |
| 3 | +$18.9M | |
| 4 |
TSVT
2seventy bio
TSVT
|
+$12.5M |
| 5 |
Clearfield
CLFD
|
+$8.92M |
Sector Composition
| 1 | Healthcare | 28.7% |
| 2 | Real Estate | 17.14% |
| 3 | Consumer Discretionary | 15.18% |
| 4 | Communication Services | 10.22% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITOS
26
DELISTED
iTeos Therapeutics
ITOS
| $5.66M | 0.86% |
+567,416
|
|
||
27
Rocket Pharmaceuticals
RCKT
$330M
| $4.9M | 0.74% |
+2,000,000
|
|
||
28
Mitek Systems
MITK
$409M
| $4.8M | 0.73% |
484,954
-236,600
|
|
||
29
Keros Therapeutics
KROS
$526M
| $3.3M | 0.5% |
+246,857
|
|
||
30
Abeona Therapeutics
ABEO
$228M
| $2.73M | 0.41% |
480,000
|
|
||
31
Wave Life Sciences
WVE
$1.18B
| $2.6M | 0.39% |
400,000
|
|
||
32
Atea Pharmaceuticals
AVIR
$231M
| $2.09M | 0.32% |
580,000
|
|
||
|
ETNB
33
DELISTED
89bio
ETNB
| $1.96M | 0.3% |
200,000
|
|
||
34
Mural Oncology
MURA
$36.2M
| $1.41M | 0.21% |
570,000
|
|
||
|
35
Clearfield
CLFD
$424M
| – | – |
-300,000
|
|
||
36
Galapagos
GLPG
$2.06B
| – | – |
-200,000
|
|
||
|
THRD
37
DELISTED
Third Harmonic Bio
THRD
| – | – |
-635,150
|
|
||
|
TSVT
38
DELISTED
2seventy bio
TSVT
| – | – |
-2,534,836
|
|
||
39
Bristow Group
VTOL
$1.12B
| – | – |
-18,080
|
|
||
|
USAR
40
USA Rare Earth Inc
USAR
$1.92B
| – | – |
-692,650
|
|